cant prove this yet

remember, these figures are estimates only and cannot be proven until the sales gather pace. The stats on new cases are freely available with some research.

here is something to consider
HepE kit rev's pa x 12yrs = us$12-15m
HepA kit rev's pa x 12yrs = us$25m-30m
HepC kit rev's pa x 12yrs = us$40-80m plus.
the figures could be much higher with outbreaks etc.


the running cost of the company are small and virtually fixed at around $1.5m pa.

Answer

can make a gross profit of up to $10m pa when sales ramp up. current market cap of $12m. these figures any where near right and the company should be trading at $100m cap and trading on a pe of around 10x. that is not a commanding pe for a diagnostic company with more to come.thats a share price of $3 in the future if i am right.

Ok lets settle down a bit
1] needs to complete the HepA deals with other US companies. Management have stated thats not far away.
2]development of a rapid HepC kit to really get the sales motoring. Mangement have stated they will keep us informed and are due to have news on that in the near future. they also told us that they entered into a deal to make the kit around 6mths ago. the tech they have works and why would the HepC kit not work?

is this a ten bagger from here?